ストックスクリーナーアプリを入手
10.60
0.00%
0.00
前日終値:
$10.60
開ける：
$10.58
24時間の取引高:
318
Relative Volume:
0.02
時価総額：
$232.22M
収益：
-
当期純損益:
$6.36M
株価収益率:
36.50
EPS:
0.2904
ネットキャッシュフロー:
$-608.40K
1週間 パフォーマンス:
+0.19%
1か月 パフォーマンス:
+0.57%
6か月 パフォーマンス:
+2.42%
1年 パフォーマンス:
+5.16%
1日の値動き範囲:
$10.58
$10.60
1週間の範囲:
$10.56
$10.60
52週間の値動き範囲:
$10.08
$10.60
Translational Development Acquisition Corp Stock (TDAC) Company Profile
名前
Translational Development Acquisition Corp
セクター
電話
(413) 204-2769
住所
52 E 83RD ST., NEW YORK
Compare TDAC vs LION, XXI, DMII, UMAC, BCSS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.60 | 232.22M | 0 | 6.36M | -608.40K | 0.2904 |
LION
Lionsgate Studios Corp
|
10.45 | 3.03B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
6.40 | 2.22B | 0 | 4.35M | 456.40K | 0.3397 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.00 | 655.75M | 0 | 0 | 0 | -0.0028 |
UMAC
Unusual Machines Inc
|
12.85 | 614.07M | 11.20M | -19.19M | -23.24M | -0.7527 |
BCSS
Bain Capital Gss Investment Corp
|
10.10 | 589.84M | 0 | 0 | 0 | 0.0729 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-09-21 | 開始されました | Northland Capital | Outperform |
Translational Development Acquisition Corp (TDAC) 最新ニュース
VION Biosciences Closes Acquisition of CTL, Strengthening Functional Immune Monitoring Capabilities - Business Wire
DYOR PE Ratio & Valuation, Is DYOR Overvalued - Intellectia AI
Spartacus Acquisition Corp. II Warrants (TMTSW) stock price, news, quote and history - Yahoo Finance Singapore
Opendoor Technologies Inc. (OPENW) stock price, news, quote and history - Yahoo Finance UK
symbol__ Stock Quote Price and Forecast - CNN
TDAC (NASDAQ: TDAC) details 2025 SPAC results, trust balance and June 2026 deadline - Stock Titan
Translational Development Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Stock List: Research Stocks from Around the World - GuruFocus
Tavia Acquisition Corp. (TAVI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Rally Mode: Is Ainos Inc a play on infrastructure spendingWeekly Risk Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Market Review: Can Translational Development Acquisition Corp outperform in the next rallyChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - StreetInsider
TDAC Should I Buy - Intellectia AI
Geopolitics Watch: Is Tapestry Inc a defensive stock2026 Historical Comparison & Daily Chart Pattern Signals - baoquankhu1.vn
Profit Recap: Is Qiagen NV part of any major indexShare Buyback & Stepwise Trade Execution Plans - baoquankhu1.vn
Gains Recap: Is Translational Development Acquisition Corp undervalued by DCF analysisPortfolio Return Summary & Reliable Price Action Trade Plans - baoquankhu1.vn
TDAC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Update: Is Newbury Street II Acquisition Corp affected by consumer sentimentMarket Growth Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Harvard Bioscience 2026 Investor Overview: Translational Science Tools, Growth Strategy, and Financial Outlook - Minichart
Buy Signal: Can HUSA generate free cash flow2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn
Retail Trends: Will NCMI benefit from AI trends2026 WrapUp & Community Trade Idea Sharing - baoquankhu1.vn
Aug Macro: Is Translational Development Acquisition Corp attractive at current valuation2026 Volatility Report & Verified Short-Term Plans - baoquankhu1.vn
Buy Signal: How liquid is TBCPW stock2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn
Volatility Watch: Is AEye Inc stock risky to hold nowTrade Exit Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Latest Lab Talk News in Brief: investment, acquisition, collaboration, R&D, awards, appointments - Laboratory Talk
Lab Talk News in Brief: investment, acquisition, collaboration, R&D, awards, appointments - Laboratory Talk
IPO Launch: Should you avoid TPST stock right nowAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Stock Recap: Is LCII a speculative investmentMarket Movers & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Movement Recap: Can Translational Development Acquisition Corp Equity Warrant expand its profit marginsPortfolio Update Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Stock Analysis: Will CIMG Inc announce a stock split2025 Short Interest & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Published on: 2026-02-21 02:25:17 - mfd.ru
Published on: 2026-02-21 08:39:55 - baoquankhu1.vn
Volume Report: Is CICXU currently under institutional pressureEarnings Overview Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
Axol Bioscience makes third acquisition in five years - Business Weekly
Axol Bioscience acquires ophthalmology business from Newcells Biotech - Cambridge Network
Can Translational Development Acquisition Corp. Equity Warrant stock double in next 5 yearsEntry Point & Daily Profit Maximizing Trade Tips - mfd.ru
Why Critical Metals Corp. stock could outperform in 2025Quarterly Market Review & Technical Entry and Exit Alerts - mfd.ru
Why NOVA stock remains resilientJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru
Growth Review: What hedge funds are buying BJRIPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
What’s the profit margin of Translational Development Acquisition Corp.Share Buyback & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Will Translational Development Acquisition Corp. stock remain a Wall Street favoritePortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru
What drives Translational Development Acquisition Corp.’s stock price2025 Trading Recap & Verified Swing Trading Watchlist - mfd.ru
Big Picture: What are ClearPoint Neuro Incs recent SEC filings showingIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
CEO Moves: Is Albany International Corps growth already priced in2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn
Aug Drivers: What is the dividend yield of QUALCOMM IncorporatedJuly 2025 Institutional & Long-Term Safe Return Strategies - baoquankhu1.vn
Risk On: Can PSAPRF outperform under higher oil pricesJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - baoquankhu1.vn
Will Zeta Global Holdings Corp. stock split attract more investors2025 Macro Impact & AI Forecast Swing Trade Picks - mfd.ru
Why is Translational Development Acquisition Corp. Equity Warrant stock going downMarket Growth Summary & Weekly Return Optimization Plans - mfd.ru
Aug Shorts: Is Translational Development Acquisition Corp. a potential multi baggerBull Run & Weekly Return Optimization Plans - baoquankhu1.vn
Large-scale multi-omics unveils host–microbiome interactions driving root development and nitrogen acquisition - Nature
Pullback Watch: Whats next for ALRS stockJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Translational Development Acquisition Corp (TDAC) 財務データ
収益
当期純利益
現金流量
EPS
0.10%
0.20%
大文字化:
|
ボリューム (24 時間):